000			01785 a2200493 4500
005			20250514193024.0
264		0	_c20040826
008			200408s 0 0 eng d
022			_a0008-5472
024	7		_a10.1158/0008-5472.CAN-03-3848 _2doi
040			_aNLM _beng _cNLM
100	1		_aMeijer-van Gelder, Marion E
245	0	0	_aUrokinase-type plasminogen activator system in breast cancer: association with tamoxifen therapy in recurrent disease. _h[electronic resource]
260			_bCancer research _cJul 2004
300			_a4563-8 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650	0	4	_aAdult
650	0	4	_aAged
650	0	4	_aAged, 80 and over
650	0	4	_aBreast Neoplasms _xdrug therapy
650	0	4	_aFemale
650	0	4	_aHumans
650	0	4	_aMiddle Aged
650	0	4	_aMultivariate Analysis
650	0	4	_aNeoplasm Recurrence, Local _xdrug therapy
650	0	4	_aPlasminogen Activator Inhibitor 1 _xmetabolism
650	0	4	_aPlasminogen Activator Inhibitor 2 _xmetabolism
650	0	4	_aProportional Hazards Models
650	0	4	_aReceptors, Cell Surface _xmetabolism
650	0	4	_aReceptors, Estrogen _xbiosynthesis
650	0	4	_aReceptors, Urokinase Plasminogen Activator
650	0	4	_aRetrospective Studies
650	0	4	_aTamoxifen _xtherapeutic use
650	0	4	_aUrokinase-Type Plasminogen Activator _xmetabolism
700	1		_aLook, Maxime P
700	1		_aPeters, Harry A
700	1		_aSchmitt, Manfred
700	1		_aBrünner, Nils
700	1		_aHarbeck, Nadia
700	1		_aKlijn, Jan G M
700	1		_aFoekens, John A
773	0		_tCancer research _gvol. 64 _gno. 13 _gp. 4563-8
856	4	0	_uhttps://doi.org/10.1158/0008-5472.CAN-03-3848 _zAvailable from publisher's website
999			_c14935877 _d14935877